The Valley Desk

NCT05977907 · Interventional trial

Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).

Overall registry status Active not recruiting

Phase 2

Conditions Head and Neck Squamous Cell Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov